Related Experiment Video

Updated: Jan 5, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.1K

Current Immune-Related Molecular Approach in Combating Nasopharyngeal Cancer

Soehartati A Gondhowiardjo1,2, Marlinda Adham1,3,

  • 1Faculty of Medicine - University of Indonesia, Jl. Salemba Raya No. 6, Jakarta 10430, Indonesia.

World Journal of Oncology
|October 23, 2019
PubMed

Insights

Nasopharyngeal cancer, linked to Epstein-Barr virus (EBV), shows promise with immunotherapies that boost T cell attacks. Combining these treatments with radiotherapy amplifies cancer cell killing, offering new hope for patients.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Nasopharyngeal cancer is strongly associated with Epstein-Barr virus (EBV) infection.
  • EBV proteins contribute to cancer development by suppressing tumor suppressors, evading immune attack, and promoting immune suppression.
  • Traditional therapies targeting these pathways have shown limited efficacy.

Purpose of the Study:

  • To explore novel therapeutic strategies for nasopharyngeal cancer.
  • To evaluate the potential of immunotherapies in enhancing anti-tumor responses.
  • To investigate the synergistic effects of combining immunotherapy with radiotherapy.

Main Methods:

  • Review of existing literature on EBV-associated nasopharyngeal cancer.
  • Analysis of studies investigating immunotherapeutic approaches, including T cell-mediated therapies.
  • Examination of research on combined treatment modalities, specifically immunotherapy and radiotherapy.

Main Results:

  • EBV proteins play a multifaceted role in oncogenesis, creating a pro-tumorigenic environment.
  • Immunotherapies designed to enhance immune cell recognition and cytotoxic T cell activity demonstrate significant clinical benefits.
  • Combination therapy, particularly immunotherapy with radiotherapy, shows amplified cancer cell destruction.

Conclusions:

  • Targeting EBV-driven oncogenic pathways is crucial for nasopharyngeal cancer treatment.
  • Immune-boosting therapies represent a promising avenue for nasopharyngeal cancer management.
  • Combining immunotherapy with radiotherapy offers a potent strategy for enhancing treatment outcomes.
Keywords:
CarcinogenesisEBVImmunotherapyNasopharyngeal cancerPD-L1

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.3K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K